Kaurus Therapeutics Company
Karus Therapeutics is a clinical-stage biopharmaceutical company. We are developing precision medicines for cancer: PI3K and HDAC6 selective inhibitors, also agents that could cross BBB.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Register and Claim Ownership